Heart pump auto mode tested in High-Risk procedure

NCT ID NCT07588399

Not yet recruiting Disease control Sponsor: Rayyan Hemetsberger Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests two ways of running a temporary heart pump (Impella CP) during a high-risk procedure to open blocked heart arteries in patients with weakened heart muscle. Fifty patients will be randomly assigned to either an automatic mode that adjusts flow or a fixed lower-flow mode, with the doctor blinded to the setting. The goal is to see if the automatic mode helps complete the procedure more successfully without complications, informing a larger future trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Impella CP heart pump
What this could lead to: If successful, this could show that an automatic pump setting helps complete high-risk heart procedures more safely, guiding larger future studies.
What could go wrong: This is a small, early pilot study with only 50 patients, so results may not apply broadly. The pump itself carries risks like bleeding or vessel damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE HEART FAILURE WITH REDUCED EJECTION FRACTION

Contacts and locations

Locations

Medical University of Vienna

Vienna, State of Vienna, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.